Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

NCT00820248 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

320

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: panitumumab
DRUG: cisplatin
RADIATION: 3-dimensional conformal radiation therapy
RADIATION: accelerated radiation therapy
RADIATION: intensity-modulated radiation therapy

Sponsor

NCIC Clinical Trials Group